Embed Size (px)
Citation preview
Global Glucose Market Report-----------------------------------------
2015
View Report Details
Executive Summary
Diabetes, often referred to as diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either
because insulin production is inadequate, or because the body’s cells do not respond properly to insulin, or both. The high blood sugar produces the
symptoms of frequent urination (polyuria), increased thirst (polydipsia), and increased hunger (polyphagia). Diabetes can cause acute complications which
include diabetic ketoacidosis and nonketotic hyperosmolar coma. Serious long-term complications include heart disease, stroke, kidney failure, foot ulcers
and damage to the eyes.
Blood Glucose Monitoring refers to the way of testing the concentration of glucose in the blood (glycemia). Monitoring blood sugar levels is an essential part
of diabetes care, as waiting for symptoms of extremely high or low blood sugar levels can result in life threatening situations. Blood sugar monitoring is done
with devices which obtain a drop of blood from a finger prick, which is then analyzed on a reagent strip. The test is generally referred to as capillary blood
glucose.
The key factors which are anticipated to drive the market include factors like increasing aging population, rising healthcare expenditure, increasing
urbanization, obese population and awareness about blood glucose monitoring. Some of the noteworthy developments of this industry include sedentary
lifestyle, increasing prevalence of diabetes, among others. However, the growth of respective industry is hindered by the barriers of regulatory risk, intense
competition, and non-invasive blood glucose monitoring, among others.
This report offers a comprehensive analysis of the global glucose monitoring industry. Furthermore, market dynamics such as key trends and development;
and challenges are analyzed in depth. On the contention front, the global glucose monitoring market is reined by few major players namely, Johnson and
Johnson, Bayer, Roche and Abbott. The competitive landscape of the respective market, along with the company profiles of the leading players are also
discussed in detail.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future of the market. We employed
various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the
industry. Before deploying the regression model, the relationship between several independent variables and the dependent variable was analyzed using
standard SPSS output, including charts, tables and tests.
View Report Details
The glucose monitoring market is by far the largest category of diabetes devices but is also……
The global glucose monitoring market reached to US$ ….
billion in 2013, marking an increase of …% in comparison
to 2012.
Traditional glucose meters comprise ….% of the global
diabetes devices market with estimated sales of about US$
…. billion in 2014.
In 2013, the market size of CGM devices increased to US$
… million, compared to US$ …. million in 2012.
Global Traditional Glucose Monitoring Market (2005-2015E)
Global Glucose Monitoring Market (2005-2013)
2005 2006 2007 2008 2009 2010 2011 2012 2013
US
$ B
illio
n
Global Continuous Glucose Monitoring Market (2005-2015E)
US
$ B
illio
n
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014E 2015E
US
$ M
illion
The CGM market is comparatively smaller than the regular glucose monitoring market as it is restricted to
the……………..
• During 2013, Glucose Strips, the main profit driver for
the glucose monitoring systems, held …% share of the
total sales. It was followed by Lancet and Glucose
meters which held …% and …% share, respectively.
The penetration of CGM systems among type 1 diabetics
in the United States has increased from roughly …% in
2010 to just …% by the end of 2013.
In 2015, the glucose monitoring market is expected to
reach US$ ….million from US$ …. million in 2008, at a
CAGR of …% during this period.
The US CGM Penetration of Type 1 Diabetics (2010-2013)
Market Share Composition of Glucose Monitoring Systems (2013)
Glucose Strips Lancet Glucose Meter Others
The US Glucose Monitoring Market (2008-2015E)
2008 2009 2010 2011 2012 2013 2014E 2015E
US
$ M
illio
n
2010 2011 2012 2013
%
With an anticipated increase in the insurance coverage of CGM expenses, the industry
will……
It is seen that in 2013, about …. thousand Type 1
diabetics are active CGM users.
As of 2014, Europe is the largest market for Type 1
CGM market opportunity with …% share. The US held
another …% share of the market.
In type 2 CGM market, Europe held …% share while
the US held …% market share.
Market Opportunity for CGM-Type 1 Diabetics by Geography (2014E)
Number of Type 1 Diabetes CGM Users in the US (2012-2016E)
2012 2013 2014E 2015E 2016E
Th
ou
san
d
Market Opportunity for CGM-Type 2 Diabetics by Geography (2014E)
Europe The US Rest of the World
Europe The US Rest of the World
Koncept Analytics
CS-36, Second Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
T. +91-120-4130959
C: +91-9811715635
Contact Us:
www.konceptanalytics.com
Vikas Gupta
BD Manager
These are abridged and sanitized sample pages from the comprehensive report on the “ Global Glucose Monitoring Market ”.
To know more about this report or for any customized research requirement, please contact the following:
View Report Details
